A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)
收藏DataMed2026-07-12 收录
官方服务：
资源简介：
This is a multicenter, open-label, Phase II trial designed to evaluate the efficacy and safety of PRO95780 when given as a single agent in patients with advanced chondrosarcoma. Up to 90 patients with confirmed chondrosarcoma will be enrolled.
提供机构：
ClinicalTrials.gov
